Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin conjugating enzyme E2 V2 pseudogene 1 (UBE2V2P1) is characterized as a pseudogene, meaning it is a genomic sequence related to the UBE2V gene family but is not believed to encode a functional enzyme or protein. Pseudogenes arise from gene duplication or retrotransposition events and often acquire mutations that render them non-functional. There is no evidence to suggest that UBE2V2P1 is expressed as a protein or plays a direct biological or pathological role. Accordingly, it is not a therapeutic target and has no known drug interactions, disease associations, or translational biomarker value. The functional gene family (UBE2V1/UBE2V2) encodes ubiquitin-conjugating E2 variant enzymes, which, in their canonical form, participate in the ubiquitination pathway (regulating protein degradation, cell signaling, and other processes). This pseudogene is sometimes annotated in error or discussed in relation to its functional paralogs, but it does not itself encode an active enzyme or therapeutic target. If a query is actually targeting a functional E2 family member (such as UBE2V1 or UBE2V2), information about those proteins should be sought separately, as they have known roles in protein ubiquitination and disease processes, whereas UBE2V2P1 itself does not. UBE2V2P1 is a pseudogene, not a functional gene, enzyme, or target. It does not encode an active protein and is not relevant for drug targeting, biomarker applications, or disease association based on current scientific knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin conjugating enzyme E2 V2 pseudogene 1 (UBE2V2P1).